Alyson J. Berliner
机构：Regeneron (United States)
发表论文 70 篇 · 总被引 9585 次 · h-index 29
代表论文
- Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial (2024 · The Lancet · 被引 243)
- Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial (2024 · The Lancet · 被引 118)
- Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration (2023 · JAMA Ophthalmology · 被引 109)
- Intravitreal Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration (2025 · Ophthalmology · 被引 25)
- Intravitreal Aflibercept 8 mg for Diabetic Macular Edema (2025 · Ophthalmology · 被引 13)
- Ocular and Systemic Risk Factors for Disease Worsening Among Patients with NPDR (2023 · Ophthalmology Retina · 被引 6)